Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q422198> ?p ?o }
Showing triples 1 to 50 of
50
with 100 triples per page.
- Q422198 subject Q7108202.
- Q422198 subject Q8798543.
- Q422198 subject Q8824860.
- Q422198 subject Q8844623.
- Q422198 abstract "Amprenavir (original brand name Agenerase, GlaxoSmithKline) is a protease inhibitor used to treat HIV infection. It was approved by the Food and Drug Administration on April 15, 1999, for twice-a-day dosing instead of needing to be taken every eight hours. The convenient dosing came at a price, as the dose required is 1,200 mg, delivered in 8 (eight) very large 150 mg gel capsules or 24 (twenty-four) 50 mg gel capsules twice daily.Production of amprenavir was discontinued by the manufacturer on December 31, 2004; a prodrug version (fosamprenavir), is available.".
- Q422198 atcPrefix "J05".
- Q422198 atcSuffix "AE05".
- Q422198 casNumber "161814-49-9".
- Q422198 chEBI "40050".
- Q422198 drugbank "DB00701".
- Q422198 fdaUniiCode "5S0W860XNR".
- Q422198 iupacName "(3S)-oxolan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)(4-aminobenzene)sulfonamido]-1-phenylbutan-2-yl]carbamate".
- Q422198 pubchem "65016".
- Q422198 thumbnail Amprenavir_structure.svg?width=300.
- Q422198 wikiPageExternalLink ?ligand=478.
- Q422198 wikiPageWikiLink Q1385311.
- Q422198 wikiPageWikiLink Q14859578.
- Q422198 wikiPageWikiLink Q15787.
- Q422198 wikiPageWikiLink Q204711.
- Q422198 wikiPageWikiLink Q212322.
- Q422198 wikiPageWikiLink Q2415654.
- Q422198 wikiPageWikiLink Q409255.
- Q422198 wikiPageWikiLink Q519410.
- Q422198 wikiPageWikiLink Q575890.
- Q422198 wikiPageWikiLink Q603741.
- Q422198 wikiPageWikiLink Q7108202.
- Q422198 wikiPageWikiLink Q7166509.
- Q422198 wikiPageWikiLink Q7251230.
- Q422198 wikiPageWikiLink Q7604197.
- Q422198 wikiPageWikiLink Q766195.
- Q422198 wikiPageWikiLink Q8798543.
- Q422198 wikiPageWikiLink Q8824860.
- Q422198 wikiPageWikiLink Q8844623.
- Q422198 wikiPageWikiLink Q9368.
- Q422198 atcPrefix "J05".
- Q422198 atcSuffix "AE05".
- Q422198 casNumber "161814".
- Q422198 chebi "40050".
- Q422198 drugbank "DB00701".
- Q422198 iupacName "-oxolan-3-yl N-[-3-hydroxy-4-[N-sulfonamido]-1-phenylbutan-2-yl]carbamate".
- Q422198 pubchem "65016".
- Q422198 unii "5".
- Q422198 type ChemicalSubstance.
- Q422198 type Drug.
- Q422198 type ChemicalObject.
- Q422198 type Thing.
- Q422198 type Q8386.
- Q422198 comment "Amprenavir (original brand name Agenerase, GlaxoSmithKline) is a protease inhibitor used to treat HIV infection. It was approved by the Food and Drug Administration on April 15, 1999, for twice-a-day dosing instead of needing to be taken every eight hours.".
- Q422198 label "Amprenavir".
- Q422198 depiction Amprenavir_structure.svg.
